Peptide questions · Retatrutide

How long does retatrutide take to work?

Reviewed Evidence: EstablishedPublished by PepVault

Retatrutide’s onset is days–2 weeks, its peak effect comes at 48+ weeks, and its typical duration is ongoing, by the library’s timeline (backed by moderate evidence).

The timeline’s basis: Phase 2 trial data (NEJM 2023), phase 3 trials (TRIUMPH-1, NEJM 2026; TRIUMPH-2, The Lancet 2026) and Lilly's phase 3 toplines. Not yet FDA-approved.

Retatrutide week by week

The library places seven of its research notes on retatrutide on the days they cover, from day 1 to day 476 and on: 6 on randomized trials and 1 on clinical data.

Day 1 is the first day of a run. Each bar is one of the library’s research notes, placed on the days it covers.

The retatrutide notes by day
WhenThe noteEvidence
Days 1–28 (weeks 1–4)Triple-agonist is kicking inRandomized trial
Days 29–84 (weeks 5–12)Dose-response steepensRandomized trial
From day 60 onWatch for dysesthesia at higher dosesRandomized trial
From day 84 onThis is a maintenance medication, not a courseClinical data
Days 85–168 (weeks 13–24)Higher steps: strong satietyRandomized trial
Days 169–336 (weeks 25–48)No plateau yet at week 48Randomized trial
Days 337–476 (weeks 49–68)Phase 3 territory: the headline numbersRandomized trial
A smiling man in a grey t-shirt in his living room, holding his phone

Model. Individual results vary.

PepVault for iPhone

Track retatrutide in PepVault

Log each dose and your weekly check-ins, and see your own weeks add up.

Download on the App Store

7 days free on the yearly plan for new subscribers.

The retatrutide timeline’s milestones

The library’s timeline for retatrutide marks 9 points from week 1 to week 80, backed by moderate evidence overall.

  • Week 1: Triple receptor activation; commonly reported: appetite suppression even stronger than on tirzepatide
  • Week 2: Commonly reported: GI side effects early on and after each dose step-up
  • Week 4: First step-up: phase 3 goes from 2 to 4mg after week 4; commonly reported: appetite much lower
  • Week 8: Second step-up, to 6mg in phase 3; commonly reported: GI effects settle within 1–2 weeks of each step
  • Week 12: Third step-up, to 9mg in phase 3; phase 2's dose steps are all done by week 12
  • Week 16: Phase 3's 12mg arm takes its last step, to 12mg; commonly reported: appetite strongly suppressed
  • Week 24: ~17% loss in phase 2 at the 8 and 12mg doses
  • Week 48: ~24% loss at the top phase 2 dose, still falling
  • Week 80: ~25% average loss at 12mg in phase 3 (TRIUMPH-1)

The weeks are the library’s reference timeline from studies and reported use, not a promise of what any one person will notice.

Why retatrutide takes that long

Retatrutide’s half-life is about 6 days (144 hours), so one dose is about 96.9% cleared after 30 days.

On its schedule (Weekly) the doses overlap, and the level of retatrutide keeps climbing for about 24–30 days before it levels off, so the first 24–30 days run below the level the later weeks hold.

The notes on retatrutide follow the trials’ dose steps, 2mg, 4mg, 9mg and 8mg, so the later weeks also describe higher steps than the first ones; these are steps from studies, not a schedule for a person.

Retatrutide against other metabolic & GLP-1 compounds

The library holds an onset-and-peak timeline for 21 metabolic & GLP-1 compounds, retatrutide among them; 15 of the others share its onset of days–2 weeks.

When metabolic & GLP-1 compounds start to act and peak, by the library’s timelines
CompoundOnsetPeak effect
SemaglutideDays–2 weeks60–68 weeks
TirzepatideDays–2 weeks72+ weeks
RetatrutideDays–2 weeks48+ weeks
DulaglutideDays–2 weeks24–52 weeks (glucose)
ExenatideFirst dose (after-meal glucose)24–30 weeks (HbA1c)
Setmelanotide1–2 weeks (hunger)52 weeks (BMI)
OrforglipronDays–2 weeks72 weeks (trial endpoint)
SurvodutideDays–2 weeks76 weeks (trial endpoint)
MazdutideDays–2 weeks48–60 weeks
PemvidutideDays–2 weeks48+ weeks
CagrilintideDays–2 weeks26–68 weeks (trial endpoints)
PramlintideFirst meal (fullness, after-meal glucose)16–52 weeks (weight, HbA1c)
CagriSemaDays–2 weeks68+ weeks
EloralintideDays–2 weeks48 weeks (phase 2 endpoint)
PetrelintideDays–2 weeks42 weeks (phase 2, still falling)
AmycretinDays–2 weeks36 weeks (longest trial so far)
VK2735Days–2 weeks78 weeks (phase 3 endpoint, not yet read out)
EnicepatideDays–2 weeks48 weeks (phase 2 endpoint, no plateau)
EcnoglutideDays–2 weeks48 weeks (phase 3, no plateau)
EfinopegdutideWeeks24–52 weeks (trial endpoints)
SLU-PP-332Unknown in peopleUnknown in people

Questions people ask

How long does retatrutide take to work?

Retatrutide’s onset is days–2 weeks, its peak effect comes at 48+ weeks, and its typical duration is ongoing, by the library’s timeline (backed by moderate evidence).

When does retatrutide reach its peak effect?

By the library’s timeline, retatrutide’s peak effect comes at 48+ weeks, backed by moderate evidence.

How long is retatrutide usually run?

The library’s timeline gives retatrutide’s typical duration as ongoing; its cycle note says: Phase 3 trials use continuous dosing.

What does the library say about the first days on retatrutide?

Its first note on retatrutide, for days 1–28 (weeks 1–4), is “Triple-agonist is kicking in”, resting on randomized trials.

More on retatrutide

Track it in the app

PepVault for iPhone

Track retatrutide in PepVault

Log each dose and your weekly check-ins, and see your own weeks add up.

Download on the App Store

7 days free on the yearly plan for new subscribers.

Explore the live demo